How AIDS-Related Opportunistic Infections Medications Work

AIDS-related opportunistic infections (OIs) are caused by pathogens that take advantage of a weakened immune system. The gold standard for treating HIV and preventing OIs is Antiretroviral Therapy (ART), which works by suppressing the replication of the virus.

• Antiretroviral Therapy (ART): ART is a combination of medications that target different stages of the viral life cycle. It includes:

• Nucleoside Reverse Transcriptase Inhibitors (NRTIs), which block the reverse transcription process

• Protease Inhibitors, which prevent the maturation of viral particles

• Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs), which also block the reverse transcription process

When ART is effective, it not only suppresses HIV replication but also reduces the risk of developing OIs. The goal of ART is to achieve a viral load below 50 copies/mL and maintain a CD4 count above 200 cells/mm³.

Alternatives and Complementary Therapies

For patients who cannot tolerate or have developed resistance to standard ART regimens, alternative classes of medications can be considered. These include:

• Protease Inhibitors: used as part of an ART regimen for patients with HIV-1 infection

• Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs): used as part of an ART regimen for patients with HIV-1 infection

• Entry Inhibitors: used to block the entry of HIV into host cells, but not currently recommended as a standard treatment option

It is essential to note that these alternative classes of medications may have different side effect profiles and potential interactions with other medications. A thorough discussion with a healthcare provider is necessary before switching or adding any new medications.